UiPath
PATH
13.07
-0.03
-0.23%
UiPath
US · PATH
#1806 by market cap
Listed 2021
13.07
-0.03
-0.23%
Live - 5344 symbols - heartbeat 160s ago
· 2026-10-08 07:32
Pre-market
13.01
-0.46%
After-hours
13.02
-0.38%
Overnight
13.06
-0.08%
- Market cap
- 6.81B
- P/E (TTM)i
- 19.51
- P/Bi
- 3.50
- EPSi
- 0.52
- Div yieldi
- 0.00%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on PATH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.05, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.65% YoY
Margins
- Gross margin
- 83.17%
- Operating margin
- 3.52%
- Net margin
- 17.53%
Key ratios & quality
- Altman Z-Scorei
- 4.05
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 148.47M | 336.16M | 607.64M | 892.25M | 1.06B | 1.31B | 1.43B | 1.61B |
| Gross profit | 106.14M | 276.75M | 541.79M | 723.38M | 878.53M | 1.11B | 1.18B | 1.34B |
| Selling & admin expenses | 296.41M | 662.97M | 542.19M | 947.67M | 941.06M | 944.77M | 964.61M | 897.62M |
| Research & development | 66.92M | 131.07M | 109.92M | 276.66M | 285.75M | 332.10M | 380.68M | 385.21M |
| Operating profit | -257.19M | -517.28M | -110.32M | -500.95M | -348.28M | -164.72M | -162.57M | 56.76M |
| Pretax profit | -258.84M | -517.14M | -94.66M | -510.88M | -317.56M | -75.82M | -78.10M | 100.63M |
| Tax | 2.81M | 2.79M | -2.27M | 14.70M | 10.79M | 14.07M | -4.41M | -181.70M |
| Net profit | -261.65M | -519.93M | -92.39M | -525.59M | -328.35M | -89.88M | -73.69M | 282.33M |
| Basic EPS | -1 | -1 | 0 | -1 | -1 | 0 | 0 | 1 |
| Diluted EPS | -0.53 | -1.06 | -0.18 | -1.16 | -0.60 | -0.16 | -0.13 | 0.52 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 356.62M | 361.73M | 411.11M | 481.11M | 418.38M | 410.26M |
| Gross profit | 292.77M | 297.35M | 342.30M | 407.17M | 341.45M | 329.67M |
| Selling & admin expenses | 214.34M | 219.19M | 232.36M | 231.73M | 220.57M | 214.67M |
| Research & development | 94.84M | 98.34M | 96.87M | 95.16M | 92.90M | 83.39M |
| Operating profit | -16.41M | -20.19M | 13.07M | 80.29M | 27.99M | 31.60M |
| Pretax profit | -19.73M | 3.33M | 24.59M | 92.44M | 40.97M | 52.86M |
| Tax | 2.83M | 1.74M | -174.25M | -12.03M | 18.44M | 16.77M |
| Net profit | -22.56M | 1.58M | 198.84M | 104.46M | 22.53M | 36.09M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | 0.00 | 0.37 | 0.19 | 0.04 | 0.07 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 400.98M | 734.43M | 2.28B | 2.34B | 2.58B | 2.34B | 2.24B |
| Cash & ST investments | -- | 232.39M | 460.52M | 1.87B | 1.76B | 1.88B | 1.63B | 1.47B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 508.17M | 866.46M | 2.57B | 2.74B | 2.95B | 2.87B | 3.18B |
| Total current liabilities | -- | 238.62M | 365.16M | 527.50M | 626.45M | 711.69M | 798.92M | 905.42M |
| Short-term debt | -- | 5.86M | 5.92M | 1.55M | 7.00M | 8.36M | 3.59M | 10.31M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | -- | 1,307,679,000.00 | 1,670,165,000.00 | 650,533,000.00 | 815,048,000.00 | 938,644,000.00 | 1,019,508,000.00 | 1,096,613,000.00 |
| Total equity | -- | -799.51M | -803.70M | 1.92B | 1.92B | 2.02B | 1.85B | 2.08B |
| Retained earnings | -- | -877.97M | -970.36M | -1.50B | -1.82B | -1.91B | -1.99B | -1.71B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.11B | 2.03B | 2.09B | 2.24B | 1.92B | 1.93B |
| Cash & ST investments | 1.56B | 1.45B | 1.40B | 1.47B | 1.31B | 1.28B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.64B | 2.59B | 2.90B | 3.18B | 2.90B | 2.91B |
| Total current liabilities | 715.87M | 738.42M | 788.70M | 905.42M | 831.67M | 807.26M |
| Short-term debt | 5.52M | 6.69M | 9.99M | 10.31M | 11.01M | 10.32M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 945,981,000.00 | 926,614,000.00 | 971,359,000.00 | 1,096,613,000.00 | 1,001,735,000.00 | 958,816,000.00 |
| Total equity | 1.70B | 1.67B | 1.92B | 2.08B | 1.90B | 1.95B |
| Retained earnings | -2.01B | -2.01B | -1.81B | -1.71B | -1.68B | -1.65B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -359.44M | 29.18M | -54.96M | -9.98M | 299.08M | 320.57M | 371.21M |
| Depreciation & amortization | -- | 15.69M | 19.60M | 14.71M | 18.72M | 22.60M | 17.23M | 16.97M |
| Free cash flow | -- | -380.42M | 25.98M | -66.79M | -33.80M | 291.74M | 305.64M | 352.16M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -128.84M | 0 | 692.37M | 0 | -102.62M | -390.75M | -329.10M |
| Ending cash balance | -- | 234.13M | 371.19M | 1.77B | 1.40B | 1.06B | 879.63M | 871.60M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 119.00M | 41.59M | 28.27M | 182.35M | 131.93M | 30.70M |
| Depreciation & amortization | 3.25M | 4.23M | 4.51M | 4.97M | 7.51M | 9.01M |
| Free cash flow | 106.17M | 41.59M | 25.11M | 179.30M | 129.24M | 29.31M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -227.53M | -101.58M | 0 | 0 | -243.80M | -24.75M |
| Ending cash balance | 701.08M | 629.06M | 744.10M | 871.60M | 633.67M | 608.89M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -94.00 | -17.09 | -4.57 | -3.82 | 14.37 |
| ROA %i | -- | -102.32 | -46.16 | -30.57 | -12.37 | -3.16 | -2.53 | 9.34 |
| ROIC %i | -- | -- | -- | -88.83 | -17.71 | -6.64 | -6.01 | 12.40 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -21.02 |
| EBIT margin %i | -173.23 | -153.88 | -18.16 | -56.14 | -32.90 | -12.59 | -11.37 | 3.52 |
| FCF / sales %i | -- | -- | 4.28 | -- | -- | 22.30 | 21.38 | 21.87 |
| Current ratioi | -- | 1.68 | 2.01 | 4.32 | 3.74 | 3.63 | 2.93 | 2.48 |
| Quick ratioi | -- | 1.47 | 1.86 | 4.16 | 3.51 | 3.37 | 2.72 | 2.27 |
| Debt / assetsi | -- | 5.17 | 2.32 | 2.00 | 2.32 | 2.27 | 2.72 | 2.56 |
| LT debt / equityi | -- | -- | -- | 2.59 | 2.94 | 2.91 | 4.02 | 3.41 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 81.81 | 46.58 | 29.12 | 17.02 | 15.01 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 123.92 | -- | -- |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -3.62 | 1.15 | 12.56 | 14.37 | 18.18 | 20.03 |
| ROA %i | -2.46 | 0.76 | 8.26 | 9.34 | 11.80 | 13.16 |
| ROIC %i | -5.79 | -0.92 | 10.02 | 12.40 | 15.94 | 17.77 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -8.92 | -3.10 | 0.65 | 3.52 | 6.05 | 8.89 |
| FCF / sales %i | 21.57 | 20.69 | 20.06 | 21.87 | 22.44 | 21.09 |
| Current ratioi | 2.95 | 2.75 | 2.65 | 2.48 | 2.31 | 2.39 |
| Quick ratioi | 2.69 | 2.48 | 2.40 | 2.27 | 2.07 | 2.14 |
| Debt / assetsi | 2.99 | 3.06 | 2.83 | 2.56 | 2.86 | 2.74 |
| LT debt / equityi | 4.32 | 4.36 | 3.74 | 3.41 | 3.78 | 3.56 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:32:52 · For reference only, not investment advice and not tailored to your situation.